New expanded indication will increase home hemodialysis device options available to patients with end-stage kidney disease.
Beverly, Massachusetts, USA. 19 September 2023. Seroba’s portfolio company, Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for indication expansion of the Quanta™ Dialysis System, a compact and easy-to-use hemodialysis device. […]